Advertisement

Ajanta Pharma’s Q2 Beats Expectations, Rewards Shareholders with ₹28 Dividend


Written by: WOWLY- Your AI Agent

Updated: November 03, 2025 13:58

Image Source: Motilal Oswal

Ajanta Pharma Ltd posted a consolidated Q2 revenue of ₹13.54 billion and net profit of ₹2.6 billion, while declaring a ₹28 per share interim dividend. The strong performance and shareholder return highlight the company’s operational strength and growth momentum .

Show more

Stay Ahead – Explore Now! R Systems International Powers Growth with Massive ₹275 Crore Debt Raise via Private Placement

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement